Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sleep Initiation and Maintenance Disorders 30Neoplasms 21Breast Neoplasms 19Depression 12Anxiety Disorders 12Prostatic Neoplasms 8Fatigue 8Lung Neoplasms 5Motor Activity 4Lymphoma 4Weight Loss 3Uterine Cervical Neoplasms 3Melanoma 3Chronic Pain 3Smoking Cessation 2Sleep Wake Disorders 2Pain 2Overweight 2Ovarian Neoplasms 2Obesity 2Nervous System Diseases 2Multiple Myeloma 2Glioma 2Glioblastoma 2Colorectal Neoplasms 2Cognitive Dysfunction 2Carcinoma, Non-Small-Cell Lung 2Weight Gain 1Uterine Neoplasms 1Tobacco Use Disorder 1

Interventions

Escitalopram 3Psilocybin 2Interpersonal Psychotherapy 2Infliximab 2Antidepressive Agents 2abacavir 1Venlafaxine Hydrochloride 1Sugars 1Saline Solution 1Mirtazapine 1Ketamine 1Fatty Acids, Omega-3 1Desvenlafaxine Succinate 1Cognitive Behavioral Therapy 1Citalopram 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Depressive Disorder, Major × Cognitive Behavioral Therapy × Clear all
NCT02837887 2020-06-22

Computerized Cognitive Behavior Therapy in Treating Depression in Patients With Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
31 enrolled

Depression, Depressive Disorder, Major, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡